ARTICLE | Clinical News
Oxabact: Phase I/II started
January 20, 2014 8:00 AM UTC
OxThera began the double-blind, placebo-controlled, European Phase I/II OC5-DB-01 trial to evaluate twice-daily oral Oxabact in 24 patients with primary hyperoxaluria. Oxabact has Orphan Drug designat...